Page 111 - Genomic Medicine in Emerging Economies

100 CHAPTER 5: Screening for Hereditary Cancer in Latin America

Villarreal-Garza, C., Alvarez-Gómez, R.M., Pérez-Plasencia, C., Herrera, L.A., Herzog, J., Castillo,
D., et al., 2015a. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in
Mexico. Cancer 121 (3), 372–378.
Villarreal-Garza, C., Weitzel, J.N., Llacuachaqui, M., Sifuentes, E., Magallanes-Hoyos, M.C., Gal-
lardo, L., et al., 2015b. The prevalence of BRCA1 and BRCA2 mutations among young Mexican
women with triple-negative breast cancer. Breast Cancer Res. Treat. 150 (2), 389–394.
Weitzel, J.N., Lagos, V.I., Herzog, J.S., Judkins, T., Hendrickson, B., Ho, J.S., et al., 2007. Evidence
for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-
risk hispanic families. Cancer Epidemiol. Biomarkers Prev. 16 (8), 1615–1620.
Weitzel, J.N., Clague, J., Martir-Negron, A., Ogaz, R., Herzog, J., Ricker, C., et al., 2013. Prevalence
and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the
southwestern United States: a report from the Clinical Cancer Genetics Community Research
Network. J. Clin. Oncol. 31 (2), 210–216.
Wielandt, A.M., Zárate, A.J., Hurtado, C., Orellana, P., Alvarez, K., Pinto, E., et al., 2012. Lynch
syndrome: selection of families by microsatellite instability and immunohistochemistry. Rev.
Méd. Chil. 140 (9), 1132–1139.
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al., 1995. Identification of
the breast cancer susceptibility gene BRCA2. Nature 378 (6559), 789–792.